Results 171 to 180 of about 50,988 (251)

Bronchial Anthracostenosis: A Rare Entity. [PDF]

Open Respir Arch
Nóvoa García C, Bernabé Barrios MJ, Nieto Barbero MA.   +2 more
europepmc   +1 more source

Characterization of a rhodopsin-phosphodiesterase from Choanoeca flexa to be combined with rhodopsin-cyclases for bidirectional optogenetic cGMP control. [PDF]

J Biol Chem
Liem N, Spreen A, Silapētere A, Hegemann P.   +3 more
europepmc   +1 more source

All-carbon supramolecular complexation of a bilayer molecular nanographene with [60] and [70]fullerenes.

Org Chem Front
Buendía M, Stasyuk AJ, Filippone S, Solà M, Martín N.   +4 more
europepmc   +1 more source

Next-generation sequencing identifies the presence of protein phosphatase 1D, PPM1D, as a potential biomarker of resistance to PARP inhibition in metastatic castration-resistant prostate cancer. [PDF]

Am J Clin Exp Urol
Vellky JE, Kirkpatrick BJ, Gutgesell LC, Kregel S, Tawagi K, Nuccio L, Vander Griend DJ, Nonn L, Reizine N.   +8 more
europepmc   +1 more source

CNG impact on combustion quality of a diesel engine fueled in diesel-gas mode. [PDF]

Heliyon
Rotaru S, Pana C, Negurescu N, Cernat A, Nutu C, Fuiorescu D, Lazaroiu G.   +6 more
europepmc   +1 more source

Promotion of endoplasmic reticulum retrotranslocation by overexpression of E3 ubiquitin-protein ligase synoviolin 1 reduces endoplasmic reticulum stress and preserves cone photoreceptors in cyclic nucleotide-gated channel deficiency. [PDF]

FASEB J
Yang F, Ma H, Boye SL, Boye SE, Ding XQ.
europepmc   +1 more source

The most common structural variant expected at the <i>GBA1</i> locus may be detected by a simple amplification method: Implications for screening Parkinson's disease variants. [PDF]

Clin Park Relat Disord
Rozenberg R, de Araujo FT, Chien HF, Barbosa ER, V Pereira L.   +4 more
europepmc   +1 more source

Alpha_Mesh_Swc: automatic and robust surface mesh generation from the skeleton description of brain cells. [PDF]

Brief Bioinform
McSweeney-Davis A, Fang C, Caruyer E, Kerbrat A, Li JR.   +4 more
europepmc   +1 more source

Case report: Near-complete response to neratinib-based treatment in HR-positive HER2-amplified metastatic breast cancer refractory to trastuzumab deruxtecan. [PDF]

Front Oncol
Tokat ÜM, Adibi A, Aydın E, Bilgiç ŞN, Özgü E, Tutar O, Demiray M.   +6 more
europepmc   +1 more source